Genmab A/S (FRA:GE9)
Germany · Delayed Price · Currency is EUR 272.50
0.00 (0.00%)
At close: Nov 28, 2025
Genmab Market Cap
Genmab has a market cap or net worth of €16.85 billion as of December 1, 2025. Its market cap has increased by 25.41% in one year.
Market Cap
16.85B
Enterprise Value
14.06B
Revenue
3.28B
Ranking
n/a
PE Ratio
12.49
Stock Price
€272.50
Market Cap Chart
Since October 18, 2000, Genmab's market cap has increased from 485.53M to 16.85B, an increase of 3,370.14%. That is a compound annual growth rate of 15.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 16.82B | 32.25% |
| Dec 30, 2024 | 12.72B | -32.67% |
| Dec 29, 2023 | 18.89B | -26.92% |
| Dec 30, 2022 | 25.84B | 11.67% |
| Dec 30, 2021 | 23.14B | 6.90% |
| Dec 30, 2020 | 21.65B | 67.74% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 50.43B |
| Siemens Healthineers AG | 47.80B |
| Bayer Aktiengesellschaft | 29.95B |
| Fresenius SE & Co. KGaA | 26.66B |
| Sartorius Aktiengesellschaft | 15.41B |
| Fresenius Medical Care AG | 11.88B |
| Carl Zeiss Meditec AG | 3.90B |
| Fielmann Group AG | 3.68B |